Abstract
Cytotoxic T lymphocytes, induced by stimulating the PBMC of an HLA-B27+ normal individual (B27+, AS-) with the PBMC of an HLA-identical sibling suffering from ankylosing spondylitis (AS) (B27+, AS+), specifically lyse B27+, AS+ PBMC but not PBMC from HLA-27+ or B27-, AS- normal controls, or from HLA-B27- AS patients (B27-,AS+). CTL of similar specificity can also be raised by immunizing in vitro B27+,AS- cells with autologous cells modified by cross-reactive bacterial antigens. These results suggest that CTL can recognize certain bacterial antigens in association with HLA-B27 and that this interaction may lead to an inflammatory episode during the initial stages of the disease.
Full Text
The Full Text of this article is available as a PDF (366.0 KB).
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Archer J. R., Stubbs M. M., Currey H. L., Geczy A. F. Antiserum to Klebsiella K43 BTS 1 specifically lyses lymphocytes of HLA-B27-positive patients with ankylosing spondylitis from a London population. Lancet. 1985 Feb 9;1(8424):344–345. doi: 10.1016/s0140-6736(85)91122-5. [DOI] [PubMed] [Google Scholar]
- Avakian H., Welsh J., Ebringer A., Entwistle C. C. Ankylosing spondylitis, HLA-B27 and Klebsiella. II. Cross-reactivity studies with human tissue typing sera. Br J Exp Pathol. 1980 Feb;61(1):92–96. [PMC free article] [PubMed] [Google Scholar]
- Geczy A. F., Alexander K., Bashir H. V., Edmonds J. A factor(s) in Klebsiella culture filtrates specifically modifies an HLA-B27 associated cell-surface component. Nature. 1980 Feb 21;283(5749):782–784. doi: 10.1038/283782a0. [DOI] [PubMed] [Google Scholar]
- McGuigan L. E., Geczy A. F., Prendergast J. K., Edmonds J. P., Hart H. H., Bashir H. V. HLA-B27 associated cross-reactive marker on the cells of New Zealand patients with ankylosing spondylitis. Ann Rheum Dis. 1986 Feb;45(2):144–148. doi: 10.1136/ard.45.2.144. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Prendergast J. K., McGuigan L. E., Geczy A. F., Kwong T. S., Edmonds J. P. Persistence of HLA-B27 cross-reactive bacteria in bowel flora of patients with ankylosing spondylitis. Infect Immun. 1984 Dec;46(3):686–689. doi: 10.1128/iai.46.3.686-689.1984. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Prendergast J. K., Sullivan J. S., Geczy A., Upfold L. I., Edmonds J. P., Bashir H. V., Reiss-Levy E. Possible role of enteric organisms in the pathogenesis of ankylosing spondylitis and other seronegative arthropathies. Infect Immun. 1983 Sep;41(3):935–941. doi: 10.1128/iai.41.3.935-941.1983. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Sullivan J., Upfold L., Geczy A. F., Bashir H. V., Edmonds J. P. Immunochemical characterization of Klebsiella antigens which specifically modify an HLA-B27-associated cell-surface component. Hum Immunol. 1982 Dec;5(4):295–307. doi: 10.1016/0198-8859(82)90021-0. [DOI] [PubMed] [Google Scholar]
- Vartak H. G., Rele M. V., Rao M., Deshpande V. V. A method for concentrating dilute solutions of macromolecules. Anal Biochem. 1983 Aug;133(1):260–263. doi: 10.1016/0003-2697(83)90252-x. [DOI] [PubMed] [Google Scholar]
- van Bohemen C. G., Grumet F. C., Zanen H. C. Identification of HLA-B27M1 and -M2 cross-reactive antigens in Klebsiella, Shigella and Yersinia. Immunology. 1984 Aug;52(4):607–610. [PMC free article] [PubMed] [Google Scholar]
- van Rood J. J., van Leeuwen A., Ivanyi P., Cats A., Breur-Vriesendorp B. S., Dekker-Saeys A. J., Kijlstra A., van Kregten E. Blind confirmation of Geczy factor in ankylosing spondylitis. Lancet. 1985 Oct 26;2(8461):943–944. doi: 10.1016/s0140-6736(85)90871-2. [DOI] [PubMed] [Google Scholar]